Titan Pharmaceuticals Inc (OTCBB - OTCQB:TTNP)

Data as of Sep 12
 -0.0134 / -2.08%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of products for the treatment of central nervous system disorders, cardiovascular disease and cancer. The company's products include Fanapt, Proneura and Probuphine. It is currently focused on three late-stage development programs for treatments of schizophrenia, opiate addiction and Parkinson's disease. Titan Pharmaceuticals was founded by Louis R. Bucalo in 1992 and is headquartered in South San Francisco, CA.

Contact Information

Titan Pharmaceuticals, Inc.
400 Oyster Point Boulevard
South San Francisco California 94080-1921
P:(650) 244-4990
Investor Relations:



Other institutional5.09%
Individual stakeholders14.72%
Mutual fund holders0.18%

Top Executives

Sunil BhonslePresident, Secretary & Director
Brian CrowleyVice President-Finance
Katherine L. Glassman-BeebeChief Development Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.